Incidence of ocular side effects of topical β blockers in the Netherlands

British Journal of Ophthalmology

Volumn 84, Issue 8, 2000, Pages 856-859

  Van Beek, Luc M ^a,d   De Keizer, Rob J W ^a   Polak, Bettine G P ^b   Elzenaar, Paul R ^c   Van Haeringen, Nicolaas J ^d   Kijlstra, Aize ^d,e  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Tramedico BV   (Netherlands)

^d NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^e WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; CARTEOLOL; LEVOBUNOLOL; METIPRANOLOL; TIMOLOL;

AGED; ARTICLE; CLINICAL ARTICLE; CONJUNCTIVA DISEASE; EYE DISEASE; EYELID DISEASE; FEMALE; HUMAN; INTERVIEW; MALE; NETHERLANDS; OPEN ANGLE GLAUCOMA; PERIORAL DERMATITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUNCTATE KERATITIS; QUESTIONNAIRE; UVEITIS;

ADMINISTRATION, TOPICAL; ADRENERGIC BETA-ANTAGONISTS; AGED; EYE DISEASES; FEMALE; HUMANS; MALE; NETHERLANDS; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; UVEITIS;

EID: 0033891945     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.84.8.856     Document Type: Article

References (21)

1. Nelson WL, Fraunfelder FT, Sills JM, et al Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985. Am J Ophthalmol 1986;102:606-11.
2. Weinreb RN, Caldwell DR, Goode SM, et el. A double-masked three-month comparison between 0.25% betaxolol suspension and 0.5% betaxolol ophthalmic solution. Am J Ophthalmol 1990;110:189-92.
3. Krieglstein GK, Novack GD, Voepel E, et al. Levobunolol and metipranolol: comparative ocular hypotensive efficacy, safety, and comfort. Br J Ophthalmol 1987;71:250-3.
4. Denffer H. Efficacy and tolerance of metipranolol: results of a multi-center long term study. In: Merte HJ, ed. Metipranolol. New York: Springer-Verlag, 1983:121-5.
5. Fiore PM, Jacobs IH, Goldberg DB. Drug-induced pemphigoid. A spectrum of diseases. Arch Ophthalmol 1987;105:1660-3.
6. Derous D, de Keizer RJ, de Wolff-Rouendaal D, et al. Conjunctival keratinisation, an abnormal reaction to an ocular beta-blocker. Acta Ophthalmol 1989;67:333-8.
7. Akingbehin T, Villada JR. Metipranolol-associated granulomatous anterior uveitis. Br J Ophthalmol 1991;75:519-23.
8. Zimmerman TJ, Baumann JD, Hetherington J Jr. Side effects of timolol. Surv Ophthalmol 1983;28(Suppl):243-51.
9. Jain S. Betaxolol-associated anterior uveitis. Eye 1994;8:708-9.
10. Burvenich H. Metipranolol associated granulomatous anterior uveitis: not so uncommon as thought. Bull Soc Belg Ophtalmol 1995;257:63-6.
11. Melles RB, Wong IG. Metipranolol-associated granulomatous iritis. Am J Ophthalmol 1994;118:712-15.
12. Watanabe TM, Hodes BL. Bilateral anterior uveitis associated with a brand of metipranolol. Arch Ophthalmol 1997;115:421-2.
13. Patel NP, Patel KH, Moster MR, et al. Metipranolol-associated nongranulomatous anterior uveitis. Am J Ophthalmol 1997;123:843-3.
14. Kessler C, Christ T. Incidence of uveitis in glaucoma patients using metipranolol. J Glaucoma 1993;2:166-70.
15. Beck KW, Moke P, Blair RC, et al. Uveitis associated with topical beta-blockers. Arch Ophthalmol 1996;114:1181-2.
16. Herbst RA, Maibach HI. Contact dermatitis caused by allergy to ophthalmias: an update. Contact Dermatitis 1992;27:335-6.
17. Rudzki E, Kecik T, Rebandel P, et al. Frequency of contact sensitivity to drugs and preservatives in patients with conjunctivitis. Contact Dermatitis 1995;33:270.
18. Perrenoud D, Bircher A, Hunziker T, et al. Frequency of sensitization to 13 common preservatives in Switzerland. Swiss Contact Dermatitis Research Group. Contact Dermatitis 1994;30:276-9.
19. O'Donnell BF, Foulds IS. Contact allergy to beta-blocking agents in ophthalmic preparations. Contact Dermatitis 1993;28:121-2.
20. Petounis AD, Akritopoulos P. Influence of topical and systemic beta-blockers on tear production. Int Ophthalmol 1989;13:75-80.
21. Kuppens EV, van Best JA, Sterk CG, et al. Decreased basal tear turnover in patients with untreated primary openangle glaucoma. Am J Ophthalmol 1995;120:41-6.